Soluble Fas and soluble FasL levels in patients with acute pancreatitis

Research Communications in Molecular Pathology and Pharmacology

Volumn 108, Issue 3-4, 2000, Pages 179-186

  Endo, Shigeatsu ^a   Inoue, Yoshihiro ^a   Fujino, Yasuhisa ^a   Yamada, Yasuhiko ^a   Sato, Nobuhiro ^a   Wakabayashi, Go ^a   Sakamoto, Teruo ^a   Ishikura, Hiroysu ^a   Tanaka, Takaya ^a   Inada, Katsuya ^a   Sato, Shigehiro ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HOMEOSTASIS; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PATHOLOGY; PRIORITY JOURNAL; SERUM;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREATITIS; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034496596     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
2. Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure
3. Involvement of the CD95 (APO-I/Fas) receptor and ligand in liver damage
4. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome
5. Fas and fas ligand: A death factor and its receptor
6. The Fas death factor
7. Purification and characterization of the Fas-ligand that induces apoptosis
8. IL-18 accounts for both TNF-α and Fas ligand-mediated hepatoxic pathways in endotoxin-induced liver injury in mice
9. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor for tumor necrosis factor